Crypt dynamics and colorectal cancer: Advances in mathematical modelling

Cell Proliferation

Volumn 39, Issue 3, 2006, Pages 157-181

  Van Leeuwen, I M M ^a   Byrne, H M ^a   Jensen, O E ^a   King, J R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; HERMES ANTIGEN; SURVIVIN; WNT PROTEIN;

ANTIGEN PRESENTING CELL; CARCINOGENESIS; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; COLORECTAL CANCER; COMPARTMENT MODEL; GENE EXPRESSION; HUMAN; INTESTINE CRYPT; MATHEMATICAL MODEL; METHYLATION; MORPHOGENESIS; NEOPLASM; NONHUMAN; PANETH CELL; REVIEW; STEM CELL; STOCHASTIC MODEL; ARTICLE; CELL FRACTIONATION; CELL MOTION; CELL TRANSFORMATION; COLORECTAL TUMOR; DNA METHYLATION; GENETICS; PATHOLOGY; THEORETICAL MODEL; TUMOR SUPPRESSOR GENE;

CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DNA METHYLATION; GENE EXPRESSION; GENES, APC; HUMANS; MODELS, THEORETICAL; SUBCELLULAR FRACTIONS;

EID: 33744979495     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2006.00378.x     Document Type: Review

References (122)

1. Adam JA, Bellomo N, eds (1997) A Survey of Models for Tumor-Immune System Dynamics Modeling and Simulation in Science, Engineering and Technology. Boston: Birkhäuser.
2. Alarcón T, Byrne HM, Maini PK (2004) Towards whole organ modelling of tumour growth. Prog. Biophys. Mol. Biol. 85, 451.
3. Ambrosi D, Bussolino F, Preziosi L (2005) A review of vasculogenesis models. J. Theor. Med. 6, 1.
4. Araujo RP, McElwain LS (2004) A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull. Math. Biol. 66, 1039.
5. Armitage P, Doll R (1954) The age distribution of cancer and a multistage theory of carcinogenesis. Br. J. Cancer 8, 1.
6. Armitage P, Doll R (1957) A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer 9, 161.
7. Bach SP, Renehan AG, Potten CS (2000) Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 21, 469.
8. Battle E, Henderson JT, Beghtel H, Van den Born MMW, Sancho E, Huls G, Meeldijk J, Robertson J, Van de Wetering M, Pawson T, Clevers H (2002) β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB. Cell 111, 251.
9. Bienz M, Clevers H (2000) Linking colorectal cancer to Wnt signaling. Cell 103, 311.
10. Bjerknes M (1996) Expansion of mutant stem cell populations in the human colon. J. Theor. Biol. 178, 381.
11. Bjerknes M, Cheng H (1999) Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology 116, 7.
12. Boland CR, Ricciardiello L (1999) How many mutations does it take to make a tumor? Proc. Natl Acad. Sci. USA 96, 14675.
13. Boman BM, Fields JZ, Bonham-Carter O, Runquist OA (2001) Computer modeling implicates stem cell overproduction in colon cancer initiation. Cancer Res. 61, 8408.
14. Booth C, Brady G, Potten CS (2002) Crowd control in the crypt. Nat. Med. 18, 1360.
15. Brodie CM, Crotty PL, Gaffney EF (2004) Morphologically distinct patterns of apoptosis correlate with size and high-grade dysplasia in colonic adenomas. Histopathology 44, 240.
16. Bry L, Falk P, Huttner K, Ouellette A, Midtvedt T, Gordon JI (1994) Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc. Natl Acad. Sci. USA 91, 10335.
17. Cairn J (2002) Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc. Natl Acad. Sci. USA 99, 10567.
18. Calabrese P, Tavaré S, Shibata D (2004) Pretumor progression. Clonal evolution of human stem cell populations. Am. J. Pathol. 164, 1337.
19. De la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat. Rev. Cancer 4, 769.
20. Drasdo D, Loeffler M (2001) Individual-based models to growth and folding in one-layered tissues: intestinal crypts and early development. Nonlinear Analysis 47, 245.
21. Duesberg P, Rausch C, Rasnick D, Hehlmann R (1998) Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc. Natl Acad. Sci. USA 95, 13692.
22. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61, 759.
23. Fidler IJ, Hart IR (1983) Biological diversity in metastatic neoplasms: origins and implications. Sci. 217, 998.
24. Fodde R (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1, 55.
25. Fodde R (2003) The multiple functions of tumour suppressors: it's all in APC. Nat. Cell Biol. 5, 190.
26. Galle J, Loeffler M, Drasdo D (2005) Modeling the effect of deregulated proliferation and apoptosis on the growth dynamics of epithelial cell populations in vitro. Biophys. J. 88, 62.
27. Gaspar C, Fodde R (2004) APC dosage effects in tumorigenesis and stem cell differentiation. Int. J. Dev. Biol. 48, 377.
28. Gerike TG, Paulus U, Potten CS, Loeffler M (1998) A dynamic model of proliferation and differentiation in the intestinal crypt based on a hypothetical intraepithelial growth factor. Cell Prolif. 31, 93.
29. Giles RH, Van Es JH, Clevers H (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1.
30. Grossmann J, Walther K, Artinger M, Rümmele P, Woenckhaus M, Schölmerich J (2002) Induction of apoptosis before shedding of human intestinal epithelial cells. Am. J. Gastroenterol. 97, 1421.
31. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57.
32. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, Da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-Myc as a target of the APC pathway. Science 281, 1509.
33. Health JP (1996) Epithelial cell migration in the intestine. Cell Biol. Int. 20, 139.
34. Hodgson SV, Maher ER (1999) A Practical Guide to Human Cancer Genetics, 2nd edn. Cambridge: Cambridge University Press.
35. Holliday R, Ho T (1998) Evidence for gene silencing by endogenous DNA methylation. Proc. Natl Acad. Sci. USA 95, 8727.
36. Homfray TFR, Cottrell SE, Ilyas M, Rowan A, Talbot IC, Bodmer WF, Tomlinson IPM (1998) Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Human Mutat. 11, 114.
37. Ilyas M (2005) Wnt signalling and the mechanistic basis of tumour development. J. Pathol. 205, 130.
38. Järvinen R, Knekt P, Hakulinen T, Rissanen H, Heliövaara M (2001) Dietary fat, cholesterol and colorectal cancer in a prospective study. Br. J. Cancer 85, 357.
39. Jones PA, Vogt PK, eds (2000) DNA Methylation and Cancer. Berlin: Springer.
40. Kaur P, Potten CS (1986) Cell migration velocities in the crypts of the small intestine after cytotoxic insult are not dependent on mitotic activity. Cell Tissue Kinet. 19, 601.
41. Kayahara T, Sawada M, Takaishi S, Fukui H, Seno H, Fukuzawa H, Suzuki K, Hiai H, Kageyama R, Okano H, Chiba T (2003) Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett. 535, 131.
42. Kerr D (2003) Clinical development of gene therapy for colorectal cancer. Nat. Rev. Cancer 3, 615.
43. Kielman MF, Rindapää M, Gaspar C, Van Poppel N, Breukel C, Van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R (2002) APC modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat. Genet. 32, 594.
44. Kim KM, Shibata D (2002) Methylation reveals a niche: stem cell succession in human colon crypts. Oncogene 21, 5441.
45. Kinzler K, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87, 159.
46. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820.
47. Knudson AG (2001) Two genetic hits (more or less) to cancer. Nat. Genet. 1, 157.
48. Komarova NL, Sengupta A, Nowak MA (2003) Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. J. Theor. Biol. 223, 433.
49. Komarova NL, Wang L (2004) Initiation of colorectal cancer: where do the two hits hit? Cell Cycle 3, 1558.
50. Komarova NL, Wodarz D (2004) The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer. Proc. Natl Acad. Sci. USA 101, 7017.
51. Kunz M, Ibrahim SM (2003) Molecular responses to hypoxia in tumor cells. Mol. Cancer 2, 23.
52. Lamprecht SA, Lipkin M (2002) Migrating colonic crypt epithelial cells: primary targets for transformation. Carcinogenesis 23, 1777.
53. Leedham SJ, Brittain M, McDonald SAC, Wright NA (2005) Intestinal stem cells. J. Cell Mol. Med. 9, 11.
54. Lifshitz S, Lamprecht SA, Benharroch D, Prinsloo I, Polak-Charcon S, Schwartz B (2001) Apoptosis (programmed cell death) in colonic cells: from normal to transformed stage. Cancer Lett. 163, 229.
55. Loeb LA (1991) Mutator phenotype may be required for multiple stage carcinogenesis. Cancer Res. 51, 3075.
56. Loeb KR, Loeb LA (2000) Significance of multiple mutations in cancer. Carcinogenesis 21, 379.
57. Loeffler M, Birke A, Winton D, Potten CS (1993) Somatic mutation, monoclonality and stochastic models of stem cell organization in the intestinal crypt. J. Theor. Biol. 160, 471.
58. Loeffler M, Bratke T, Paulus U, Li YQ, Potten CS (1997) Clonality and life cycles of intestinal crypts explained by a state dependent stochastic model of epithelial stem cell organization. J. Theor. Biol. 186, 41.
59. Loeffler M, Grossmann B (1991) A stochastic branching model with formation of subunits applied to the growth of intestinal crypts. J. Theor. Biol. 150, 175.
60. Loeffler M, Potten CS, Paulus U, Glatzer J, Chwalinski S (1988) Intestinal crypt proliferation. II. Computer modelling of mitotic index data provides further evidence for lateral and vertical cell migration in the absence of mitotic activity. Cell Tissue Kinet. 21, 247.
61. Loeffler M, Stein R, Wichmann HE, Potten CS, Kaur P, Chwalinski S (1986) Intestinal crypt proliferation. I. A comprehensive model of steady-state proliferation in the crypt. Cell Tissue Kinet. 19, 627.
62. Luebeck EG, Moolgavkar SH (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proc. Natl Acad. Sci. USA 99, 15095.
63. MacPhee DG (1998) Epigenetics and epimutagens: some new perspectives on cancer, germ line effects and endocrine disrupters. Mutat. Res. 400, 369.
64. Mantzaris NV, Webb S, Othmer HG (2004) Mathematical modeling of tumor-induced angiogenesis. J. Math. Biol. 49, 111.
65. Marshman E, Booth C, Potten CS (2002) The intestinal epithelial stem cell. Bioessays 24, 91.
66. Meineke FA, Potten CS, Loeffler M (2001) Cell migration and organization in the intestinal crypt using a lattice-free model. Cell Prolif. 34, 253.
67. Merok JR, Lansita JA, Tunstead JR, Sherley JL (2002) Cosegregation of chromosomes containing immortal DNA strands in cells that cycle with asymmetric stem cell kinetics. Cancer Res. 62, 6791.
68. Morel D, Marcelpoil R, Brugal G (2001) A proliferation control network model: the simulation of two-dimensional epithelial homeostasis. Acta Biotheor 49, 219.
69. Noble D (2002) Modeling the heart - from genes to cell to the whole organ. Science 295, 1678.
70. Nordling CO (1953) A new theory on the cancer-inducing mechanism. Br. J. Cancer 7, 68.
71. Novelli M, Cossu A, Oukrif D, Quaglia A, Lakhani S, Poulsom R, Sasieni P, Carta P, Contini M, Pasca A, Palmieri G, Bodmer W, Tanda F, Wright N (2003) X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc. Natl Acad. Sci. USA 100, 3311.
72. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih IM, Vogelstein B, Lengauer C (2002) The role of chromosomal instability in tumor initiation. Proc. Natl Acad. Sci. USA 99, 16226.
73. Nowak MA, Michor F, Iwasa Y (2003) The linear process of somatic evolution. Proc. Natl Acad. Sci. USA 100, 14966.
74. Nowak MA, Michor F, Iwasa Y (2004) Evolutionary dynamics of tumor suppressor gene inactivation. Proc. Natl Acad. Sci. USA 101, 10635.
75. Nowel PC (1976) The clonal evolution of tumor cell populations. Science 194, 23.
76. Okamoto R, Watanabe M (2004) Molecular and clinical basis for the regeneration of human gastrointestinal epithelia. J. Gastroenterol. 39, 1.
77. Paulus U, Loeffler M, Zeidler J, Owen G, Potten CS (1993) The differentiation and lineage development of goblet cells in the murine small intestinal crypt: experimental and modelling studies. J. Cell Sci. 106, 473.
78. Paulus U, Potten CS, Loeffler M (1992) A model of the control of cellular regeneration in the intestinal crypt after perturbation based solely on local stem cell regulation. Cell Prolif. 25, 559.
79. Potten CS, Booth C, Hargreaves D (2003) The small intestine as a model for evaluating adult tissue stem cell drug targets. Cell Prolif. 36, 115.
80. Potten CS, Loeffler M (1990) Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons from the crypt. Development 110, 1001.
81. Potten CS, Owen G, Booth C (2002) Intestinal stem cells protect their genome by selective segregation of template DNA strands. J. Cell Sci. 115, 2381.
82. Potten CS, Roberts SA, Chwalinski S, Paulus U (1988) Scoring mitotic activity in longitudinal sections of crypts of the small intestine. Cell Tissue Kinet. 21, 231.
83. Potter JD (1999) Colorectal cancer: molecules and populations. J. Natl Cancer Inst. 91, 916.
84. Preston SL, Wong WM, Chan AOO, Poulson R, Jeffery R, Goodlad RA, Mandir N, Elia G, Novelli M, Bodmer WF, Tomlinson IP, Wright NA (2003) Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res. 63, 3819.
85. Preziosi L, ed. (2003) Cancer Modelling and Simulation. Boca Raton, FL: CRC Press.
86. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C (2003) The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 3, 695.
87. Renehan AG, O'Dwyer ST, Haboubi NJ, Potten CS (2002) Early cellular events in colorectal carcinogenesis. Colorectal Dis. 4, 76.
88. Ro S, Rannala B (2001) Methylation patterns and mathematical models reveal dynamics of stem cell turnover in the human colon. Proc. Natl Acad. Sci. USA 98, 10519.
89. Roberts SA, Hendry JH, Potten CS (1995) Deduction of the clonogen content of intestinal crypts: a direct comparison of two-dose and multi-dose methodologies. Radiat. Res. 141, 303.
90. Ross MH, Kaye GI, Pawlina W (2003) Histology: A Text & Atlas. Philadelphia: Lippincott Williams & Wilkins.
91. Schmidt GH, Wilkinson MM, Ponder BA (1985) Cell migration pathway in the intestinal epithelium: an in situ marker system using mouse aggregation chimeras. Cell 40, 425.
92. Shih IM, Wang TL, Traverson G, Romans K, Hamilton SR, Ben-Sasson S, Kinzler KW, Vogelstein B (2001a) Top-down morphogenesis of colorectal tumors. Proc. Natl Acad. Sci. USA 98, 2640.
93. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B (2001b) Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res. 61, 818.
94. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A (1999) The cycling D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA 96, 5522.
95. Sieber OM, Heinimann K, Gorman P, Lamlum H, Crabtree M, Simpson CA, Davies D, Neale K, Hodgson SV, Roylance RR, Phillips RKS, Bodmer WF, Tomlinson IPM (2002) Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc. Natl Acad. Sci. USA 99, 16910.
96. Sieber OM, Heinimann K, Tomlinson IPM (2003) Genomic instability - the engine of tumourigenesis? Nat. Rev. Cancer 3, 701.
97. Smallwood RH, Holcombe WML, Walker DC (2004) Development and validation of computational models of cellular interaction. J. Mol. Histol. 35, 659.
98. Smith G, Carey FA, Beattie J, Wilkie MJV, Lightfoot TJ, Coxhead J, Garner RC, Steele RJC, Wolf CR (2002) Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer. Proc. Natl Acad. Sci. USA 99, 9433.
99. Spradling A, Drummond-Barboa D, Kai T (2001) Stem cells find their niche. Nature 414, 98.
100. Steward BW, Kleihues P, eds (2003) World Cancer Report. Lyon, France: IARC Press.
101. Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240, 177.
102. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36, 417.
103. Tomlinson IPM, Bodmer WF (1995) Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc. Natl Acad. Sci. USA 92, 11130.
104. Tomlinson IPM, Novelli MR, Bodmer WF (1996) The mutation rate and cancer. Proc. Natl Acad. Sci. USA 93, 14800.
105. Tomlinson IPM, Sasieni P, Bodmer WF (2002) How many mutations in a cancer? Am. J. Pathol. 160, 755.
106. Trier JS, Allan CH, Abrahamson DR, Hagen SJ (1990) Epithelial basement membrane of mouse jejunum. Evidence for laminin turnover along the entire crypt-villus axis. J. Clin. Invest. 86, 87.
107. Tsao JL, Tavaré S, Salovaara R, Jass JR, Aaltonen LA, Shibata D (1999) Colorectal adenoma and cancer divergence. Evidence of multilineage progression. Am. J. Pathol. 154, 1815.
108. Tsao JL, Yatabe Y, Salovaara R, Järvinen HJ, Mecklin JP, Aaltonen LA, Tavaré S, Shibata D (2000) Genetic reconstruction of individual colorectal tumor histories. Proc. Natl Acad. Sci. USA 97, 1236.
109. Turck N, Gross I, Gendry P, Stutzmann J, Freund JN, Kedinger M, Simon-Assmann P, Launay JF (2005) Laminin isoforms: biological roles and effects on the intracellular distribution of nuclear proteins in intestinal epithelial cells. Exp. Cell Res. 303, 494.
110. Van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, Van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, Van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H (2002) The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241.
111. Van Leeuwen IMM, Zonneveld C (2001) From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis. Mutat. Res. 489, 17.
112. Veigl ML, Kasturi L, Olechnowicz J, Ma A, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Mondrich PL, Sedwick WD, Markowitz SD (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl Acad. Sci. USA 95, 8698.
113. Venook A (2005) Critical evaluation of current treatment in metastatic colorectal cancer. Oncologist 10, 250.
114. Walker DC, Southgate J, Hill G, Holcombe M, Hose DR, Wood SM, MacNeil S, Smallwood RH (2004) The epitheliome: agent-based modelling of the social behaviour of cells. Biosystems 76, 89.
115. Waters J, Cunningham D (2001) The changing face of chemotherapy in colorectal cancer. Br. J. Cancer 84, 1.
116. Winton DJ, Blount MA, Ponder BA (1988) A clonal marker induced by mutation in mouse intestinal epithelium. Nature 333, 463.
117. Winton DJ, Ponder BA (1990) Stem-cell organization in mouse small intestine. Proc. Biol. Sci. 241, 13.
118. Wodarz D, Komarova NL (2005) Computational Biology of Cancer: Lecture Notes and Mathematical Modeling. Hackensack, NJ: World Scientific Publishing.
119. Wright NA (2000) Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer. Int. J. Exp. Pathol. 81, 117.
120. Yatabe Y, Tavaré S, Shibata D (2001) Investigating stem cells in human colon by using methylation patterns. Proc. Natl Acad. Sci. USA 98, 10839.
121. Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ, Boman BM (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colorectal cancer. Cancer Res. 61, 8664.
122. Zingg JM, Jones PA (1997) Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18, 869.